Objectives: To compare outcomes after carotid endarterectomy (CEA) with saphenous vein patch closure (SV), with cervical vein (external jugular and common facial) patch closure (CV).
Design: A total of 322 cases of CEA was achieved consecutively by using venous patch angioplasty. Propensity scores were calculated followed by a one-to-one basis case-matching.
Materials: This resulted into 90 SV and 90 CV matched cases.
Methods: The primary endpoint was the incidence of ipsilateral stroke and transient ischaemic attack at any time during follow-up.
Results: Ten-year freedom from stroke was 94.1% ± 3.5% for the SV group and 90.5% ± 4.2% for the CV group (log rank P = 0.230). Ten-year freedom from ipsilateral neurological events (stroke and transient ischaemic attack) was 93.5% ± 3.3% for SV group and 92.4% ± 3.0% for the CV group (log rank P = 0.403). Ten-year freedom from ≥75% stenosis/occlusion was 93.1 ± 4.8% for the SV group and 89.9 ± 6.0% for the CV group (log rank P = 0.481).
Conclusions: CV is a good alternative to SV patching, particularly when the SV needs to be preserved for further use or is unsuitable.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ejvs.2011.08.017 | DOI Listing |
J Clin Med
October 2024
Department of Cardiac Surgery, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Cardiol Young
October 2024
Department of Pediatric and Congenital Heart Surgery, Division of Pediatric Cardiac Surgery, Heart, Vascular, and Thoracic Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Objectives: We assessed the effect of anomalous aortic origin of a coronary artery on the risk of early and late postoperative events after aortic or mitral valve replacement in adults.
Methods: Between 2005 and 2022, 29,579 adults underwent surgical aortic or mitral valve replacement at Cleveland Clinic. Among these, 29 had an unrepaired coronary artery rising anomalously from the aorta that was not intervened upon during valve surgery, 19 (65%) an anomalous circumflex, and 9 (31%) an anomalous right.
Ann Cardiothorac Surg
September 2024
Department of Cardiovascular & Thoracic Surgery, Lenox Hill Hospital/Northwell Health, New York, NY, USA.
Background: Hybrid coronary revascularization (HCR) is a well-established technique for treating multi-vessel coronary disease. There remains a paucity of discussion assessing the efficacy of HCR with respect to the timing of the surgical component relative to that of the percutaneous coronary intervention (PCI).
Methods: A retrospective review was undertaken of our prospectively collected database from January 2009 to December 2019.
Front Cardiovasc Med
October 2024
Department of Cardiovascular Surgery, Faculty of Medicine, Ege University, Izmir, Türkiye.
J Cardiothorac Surg
October 2024
Heart Center, King Faisal Specialist Hospital & Research Center (KFSHRC), PO Box 3354, Riyadh, 11211, Saudi Arabia.
Background: The incidence of infective endocarditis (IE) in patients undergoing redo mitral valve (MV) surgery was evaluated. The outcomes of all the patients and the patients' specific characteristics were recorded. The patients were analyzed to further the research of IE in this population.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!